A phase 3 study of Sildenafil Cream for the treatment of Female sexual dysfunction
Latest Information Update: 21 Nov 2024
Price :
$35 *
At a glance
- Drugs Sildenafil (Primary)
- Indications Female sexual dysfunction
- Focus Registrational; Therapeutic Use
- 21 Nov 2024 New trial record
- 14 Nov 2024 According to a Dare Bioscience media release, this phase 3 study will be required to support an NDA for Sildenafil Cream for the treatment of FSAD and company anticipates that each Phase 3 study will be approximately $15.0 million in direct costs.